Erlotinib-associated skin reactions -: case report and proposal for classification

被引：4

作者：

Zoller, A. ^{[1
]}

Schaed, S. G. ^{[1
]}

Gross, G. E. ^{[1
]}

机构：

[1] Univ Rostock, Dept Dermatol & Venerol, D-18055 Rostock, Germany

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2006年 / 155卷 / 06期

关键词：

D O I：

10.1111/j.1365-2133.2006.07519.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 [皮肤病与性病学];

摘要：

引用

页码：1293 / 1295

页数：3

共 10 条

[1]

Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer [J].

Bunn, PA ;

Franklin, W .

SEMINARS IN ONCOLOGY, 2002, 29 (05) :38-44

[2]

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225 [J].

Busam, KJ ;

Capodieci, P ;

Motzer, R ;

Kiehn, T ;

Phelan, D ;

Halpern, AC .

BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1169-1176

[3]

Gutzmer R, 2006, HAUTARZT, V57, P509, DOI 10.1007/s00105-005-1033-3

[4]

National Cancer Institute, 2003, COMM TERM CRIT ADV E

[5]

Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer [J].

Pérez-Soler, R ;

Chachoua, A ;

Hammond, LA ;

Rowinsky, EK ;

Huberman, M ;

Karp, D ;

Rigas, J ;

Clark, GM ;

Santabàrbara, P ;

Bonomi, P .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3238-3247

[6]

Perez-Soler Roman, 2003, Oncology (Williston Park), V17, P23

[7]

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors [J].

Segaert, S ;

Van Cutsem, E .

ANNALS OF ONCOLOGY, 2005, 16 (09) :1425-1433

[8]

Segaert Siegfried, 2005, J Dtsch Dermatol Ges, V3, P599, DOI 10.1111/j.1610-0387.2005.05058.x

[9]

Erlotinib in previously treated non-small-cell lung cancer [J].

Shepherd, FA ;

Pereira, JR ;

Ciuleanu, T ;

Tan, EH ;

Hirsh, V ;

Thongprasert, S ;

Campos, D ;

Maoleekoonpiroj, S ;

Smylie, M ;

Martins, R ;

van Kooten, M ;

Dediu, M ;

Findlay, B ;

Tu, DS ;

Johnston, D ;

Bezjak, A ;

Clark, G ;

Santabárbara, P ;

Seymour, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132

[10]

Erlotinib in lung cancer - Molecular and clinical predictors of outcome [J].

Tsao, MS ;

Sakurada, A ;

Cutz, JC ;

Zhu, CQ ;

Kamel-Reid, S ;

Squire, J ;

Lorimer, I ;

Zhang, T ;

Liu, N ;

Daneshmand, M ;

Marrano, P ;

Santos, GD ;

Lagarde, A ;

Richardson, F ;

Seymour, L ;

Whitehead, M ;

Ding, KY ;

Pater, J ;

Shepherd, FA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :133-144

← 1 →